SANGAMO THERAPEUTICS, INC Annual Return On Equity in % from 2018 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sangamo Therapeutics, Inc quarterly/annual Return On Equity history and growth rate from 2018 to 2022.
  • Sangamo Therapeutics, Inc Return On Equity for the quarter ending March 31, 2023 was -40.4 %, a 10.5% increase year-over-year.
  • Sangamo Therapeutics, Inc annual Return On Equity for 2022 was -61.2 %, a 45.5% decline from 2021.
  • Sangamo Therapeutics, Inc annual Return On Equity for 2021 was -42 %, a 67.1% decline from 2020.
  • Sangamo Therapeutics, Inc annual Return On Equity for 2020 was -25.2 %, a 7.52% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -61.2 -19.2 -45.5% Jan 1, 2022 Dec 31, 2022
2021 -42 -16.9 -67.1% Jan 1, 2021 Dec 31, 2021
2020 -25.2 -1.76 -7.52% Jan 1, 2020 Dec 31, 2020
2019 -23.4 -2.65 -12.8% Jan 1, 2019 Dec 31, 2019
2018 -20.8 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.